Communiqué de Presse
BIOCORP: 2020 financial calendar
Issoire, France, January 9th, 2020, 08h00 am CET - BIOCORP (FR0012788065 - ALCOR / Eligible PEA PME), a French company specialized in the development and manufacturing of medical devices and smart drug delivery systems, updates its financial reporting schedule for
2020*:
Annonce | Date* | ||
2019 full-year results | Thursday, April 9th, 2020 | ||
Before the market opening | |||
Annual shareholders meeting | Friday, May 15th, 2020 | ||
2020 first-half results | Thursday, September 24th, 2020 | ||
After the market close | |||
- This schedule is indicative and subject to change.
À PROPOS DE BIOCORP
Recognized for its expertise in the development and manufacture of medical devices and delivery systems, BIOCORP has today acquired a leading position in the connected medical device market thanks to Mallya. This intelligent sensor for insulin injection pens allows reliable monitoring of injected doses and thus offers better compliance in the treatment of diabetics. Available for sale from 2020, Mallya spearheads BIOCORP's product portfolio of innovative connected solutions. The company has 54 employees.
BIOCORP is listed on Alternext since July 2015 (FR0012788065 - ALCOR). For more information, please visit www.biocorpsys.com
Follow us on Twitter @BIOCORPSystems
BIOCORP CONTACTS | ||
Jacques Gardette | Éric Dessertenne | Sylvaine Dessard |
Chairman of the Board | CEO | Marketing @ Communication Director |
investisseurs@biocorp.fr | rp@biocorp.fr | |
+ 33 (0)6 88 69 72 85 | ||
ULYSSE COMMUNICATION CONTACTS | ||
Bruno ARABIAN | Nicolas DANIELS | |
barabian@ulysse-communication.com | ndaniels@ulysse-communication.com | |
+33 (0)6 87 88 46 26 | +33 (0)6 63 66 59 22 |
Attachments
- Original document
- Permalink
Disclaimer
Biocorp Production SA published this content on 09 January 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 09 January 2020 08:02:00 UTC